| Literature DB >> 27830722 |
Yoshihiko Usui1, Narsing A Rao2, Hiroshi Takase3, Kinya Tsubota1, Kazuhiko Umazume1, Daniel Diaz-Aguilar4, Takeshi Kezuka1, Manabu Mochizuki3,5, Hiroshi Goto1, Sunao Sugita6,7.
Abstract
Infectious agents have been identified as a major cause of specific types of human cancers worldwide. Several microorganisms have been identified as potential aggravators of ocular adnexal neoplasms; however, given the rarity of these neoplasms, large epidemiological studies are difficult to coordinate. This study aimed to conduct an exhaustive search for pathogenic DNA in lymphoproliferative disorders (LPD) of the ocular adnexa in a total of 70 patients who were diagnosed with LPD of the ocular adnexa between 2008 and 2013. Specimens were screened for bacterial, viral, fungal, and parasitic DNA by multiplex polymerase chain reaction (PCR) and quantitative real-time PCR. Among cases of conjunctival mucosa-associated lymphoid tissue lymphoma, human herpes virus (HHV)-6, HHV-7, chlamydia, Epstein-Barr virus (EBV) and bacterial 16S ribosomal DNA were detected. In cases of IgG4-related ocular disease, similar pathogens were detected but in a larger number of patients. Our PCR assays detected DNAs of various infectious agents in tumor specimens, especially HHV6, HHV7, and EBV, with different positive rates in various types of LPD. Chronic inflammatory stimulation or activation of oncogenes from these infectious agents might be involved in the pathogenesis of LPD of the ocular adnexa.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27830722 PMCID: PMC5103257 DOI: 10.1038/srep36621
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Representative real-time PCR results of a tumor sample obtained from a case of IgG4-related ophthalmic disease.
The sample is positive for HHV7-DNA, with 1.24 × 106 copies/μg DNA. Control DNA: standard HHV7-DNA (106, 104, 102 copies).
Positive rates for various microorganisms detected by comprehensive polymerase chain reaction assays in tumor specimens of 70 patients with lymphoproliferative disorders of the ocular adnexa.
| Infectious agent | Multiplex PCR and Real-time PCR | ||||
|---|---|---|---|---|---|
| Conjunctival MALT | Orbital MALT | Orbital DLBCL | IgG4-ROD | Orbital RLH | |
| EBV | 3/19 (15.8%) | 0/15 (0%) | 2/7 (28.6%) | 7/22 (31.8%) | 2/7 (28.6%) |
| HHV-6 | 1/19 (5.2%) | 1/15(6.7%) | 0/7 (0%) | 5/22 (22.7%) | 2/7 (28.6%) |
| HHV-7 | 1/19 (5.2%) | 0/15 (0%) | 0/7 (0%) | 8/22 (36.4%) | 3/7 (42.9%) |
| Chlamydia | 1/19 (5.2%) | 0/15 (0%) | 0/7 (0%) | 0/22 (0%) | 0/7 (0%) |
| Bacteria | 2/19 (10.5%) | 0/15 (0%) | 1/7 (14.3%) | 1/22 (4.5%) | 1/7 (14.3%) |
PCR, polymerase chain reaction; MALT, mucosa-associated lymphoid tissue lymphoma; DLBCL, diffuse large B-cell lymphoma; IgG4-ROD, IgG4-related ophthalmic disease; RLH, reactive lymphoid hyperplasia; EBV, Epstein-Barr virus; HHV, human herpes virus.
Multiple positive rates detected by comprehensive polymerase chain reaction assays in biopsy specimens of 70 patients with lymphoproliferative disorders of the ocular adnexa.
| Number of patients with double positive (%) | Number of patients with triple positive (%) | Number of patients with quadruple positive (%) | |
|---|---|---|---|
| Conjunctival MALT | 2/19 (10.5) | 0/19 (0) | 0/19 (0) |
| HHV-6 + EBV: 1 case | |||
| HHV-7 + EBV: 1 case | |||
| Orbital MALT | 0/15 (0) | 0/15 (0) | 0/15 (0) |
| Orbital DLBCL | 1/7 (14.3) | 0/7 (0) | 0/7 (0) |
| EBV + Bacteria: 1 case | |||
| IgG4-ROD | 7/22 (31.8) | 1/22 (4.5) | 0/22 (0) |
| HHV-6 + HHV-7: 2 cases | HHV-6 + HHV-7 + EBV: 1 case | ||
| HHV-6 + EBV: 2 cases | |||
| HHV-7 + EBV: 2 cases | |||
| EBV + Bacteria: 1 case | |||
| RLH | 0/7 (0) | 0/7 (0) | 1/7 (14.3) |
| HHV-6 + HHV-7 + EBV + Bacteria: 1 case |
MALT, mucosa-associated lymphoid tissue lymphoma; DLBCL, diffuse large B-cell lymphoma; IgG4-ROD, IgG4-related ophthalmic disease; RLH, reactive lymphoid hyperplasia; HHV, human herpes virus; EBV, Epstein-Barr virus.
Patient characteristics and monoclonality status of IgH gene rearrangement.
| Conjunctival MALT | Orbital MALT | Orbital DLBCL | IgG4-ROD | Orbital RLH | |
|---|---|---|---|---|---|
| Number | 19 | 15 | 7 | 22 | 7 |
| Age (yrs) | 50.8 ± 18.0 | 70.8 ± 13.9 | 64.4 ± 14.2 | 60.5 ± 15.5 | 55.7 ± 13.4 |
| Men/Women | 7/12 | 7/8 | 4/3 | 12/10 | 2/5 |
| IgH gene rearrangement | all (+) | all (+) | all (+) | all (−) | all (−) |
MALT, mucosa-associated lymphoid tissue lymphoma; DLBCL, diffuse large B-cell lymphoma; IgG4-ROD, IgG4-related ophthalmic disease; RLH, reactive lymphoid hyperplasia; IgH, immunoglobulin heavy chain.